铁死亡在肝脏代谢性疾病中的作用机制研究进展OA
Research progress on mechanism of ferroptosis in metabolic liver diseases
铁死亡(ferroptosis)是一种铁依赖性的、由脂质过氧化驱动的调节性细胞死亡形式,其在生化机制与细胞形态学特征上均不同于凋亡、坏死性凋亡、焦亡及铜死亡.该综述主要探讨铁稳态、脂质过氧化与代谢功能障碍相关脂肪性肝病(metabolic dysfunction-associated fatty liver disease,MASLD)及其可能进展为肝细胞癌(hepatocellular carcinoma,HCC)之间的内在联系.研究表明,铁代谢失衡(特别是铁死亡)通过芬顿反应产生活性氧(reactive oxygen species,ROS),是触发脂质过氧化和铁死亡的关键因素.在MASLD中,铁死亡参与了从单纯性脂肪变性向代谢功能障碍相关性脂肪性肝炎(metabolic dysfunction-associated steatohepatitis,MASH)和肝纤维化的进展.而在HCC中,铁死亡扮演着复杂的角色,一方面,它可作为内在的肿瘤抑制机制清除恶性细胞;另一方面,癌细胞通过获得铁死亡抵抗能力,进而促进肿瘤进展并导致对靶向药物的耐受.理解这些机制为开发针对MASLD和HCC的新治疗策略提供了潜在靶点.
Ferroptosis is an iron-dependent,lipid peroxidation-driven form of regulatory cell death that differs from apoptosis,necrotic apoptosis,pyroptosis,and copper-induced cell death in both biochemical mechanisms and cellular morphological characteristics.This review explores the intrinsic linkages be-tween iron homeostasis,lipid peroxidation,metabolic dysfunction-associated fatty liver disease(MASLD),and its po-tential progression to hepatocellular carcinoma(HCC),based on current research.Research indicates that iron metabolism imbalance—particularly ferroptosis—triggers lipid peroxidation and ferroptosis by generating reactive oxygen species(ROS)via the Fenton reaction.In MASLD,ferroptosis participates in the progression from simple steatosis to metabolic dysfunction-associated steatohepatitis(MASH)and liver fibrosis.In HCC,ferroptosis plays a complex dual role:it functions as an intrinsic tumor suppression mechanism eliminating malignant cells while enabling cancer cells to acquire ferroptosis resistance,thereby promoting tumor progression and inducing tolerance to targeted therapies.Understanding these mechanisms provides potential targets for developing novel therapeutic strategies against both MASLD and HCC.
王钰萱;赵永旭
中国科学院上海药物研究所代谢疾病研究中心,上海 201203||中国科学院大学,北京 100049中国科学院上海药物研究所代谢疾病研究中心,上海 201203||中国科学院大学,北京 100049||烟台新药创制山东省实验室,山东 烟台 264117
医药卫生
铁死亡代谢功能障碍相关脂肪性肝病肝细胞癌脂质过氧化氧化应激
ferroptosismetabolic dysfunction-associated fatty liver diseasehepatocellular carcinomalipid peroxidationoxi-dative stress
《中国药理学通报》 2026 (4)
601-606,6
国家自然科学基金面上项目(No 82070824)山东省重点研发计划(No 2024CXPT028)
评论